Intraoperative Fluorescence With Augmented Reality

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
Vascular; Lesion, Central Nervous SystemBrain TumorCerebral AneurysmCerebral AVM
Interventions
DEVICE

GLOW800

The treatment group will consist of patients who require a medically necessary craniotomy. If an investigator deems that it will be useful to see blood vessels better with indocyanine green (ICG) videoangiography (VA), patients may be consented for the use if ICG VA using augmented reality (GLOW800). This will not add additional time or risk to their surgery

DRUG

indocyanine green (ICG)

This is a standard medication which can be given IV during a surgery to better visualize blood vessels under the microscope

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT03888014 - Intraoperative Fluorescence With Augmented Reality | Biotech Hunter | Biotech Hunter